Castle Biosciences Inc (CSTL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2024 | 09-2024 | 06-2024 | 03-2024 | 12-2023 | |
| Sales | 86,311 | 85,782 | 87,002 | 72,974 | 66,120 |
| Cost of Goods | 16,183 | 15,609 | 14,519 | 13,894 | 12,423 |
| Gross Profit | 70,128 | 70,173 | 72,483 | 59,080 | 53,697 |
| Operating Expenses | 66,261 | 65,703 | 67,990 | 65,445 | 59,778 |
| Operating Income | 4,050 | 5,079 | 5,012 | -5,471 | -5,658 |
| Interest Expense | 92 | 201 | 270 | 14 | 2 |
| Other Income | 3,927 | 3,404 | 3,144 | 2,996 | 3,119 |
| Pre-tax Income | 7,885 | 8,282 | 7,886 | -2,489 | -2,541 |
| Income Tax | -1,705 | 6,013 | -1,034 | 45 | 39 |
| Net Income Continuous | 9,590 | 2,269 | 8,920 | -2,534 | -2,580 |
| Net Income | $9,590 | $2,269 | $8,920 | $-2,534 | $-2,580 |
| EPS Basic Total Ops | 0.35 | 0.08 | 0.32 | -0.09 | -0.08 |
| EPS Basic Continuous Ops | 0.34 | 0.08 | 0.32 | -0.09 | -0.09 |
| EPS Diluted Total Ops | 0.32 | 0.08 | 0.31 | -0.09 | -0.08 |
| EPS Diluted Continuous Ops | 0.33 | 0.08 | 0.31 | -0.09 | -0.09 |
| EPS Diluted Before Non-Recurring Items | 0.32 | 0.08 | 0.31 | N/A | N/A |
| EBITDA(a) | $8,205 | $6,970 | $6,637 | $-3,830 | $-4,074 |